Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 06-2024 | 06-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,064 | -4,427 | -7,312 | -11,114 | -996 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 30 |
| Accounts payable and accrued liabilities | 550 | 4 | -9,333 | 8,388 | N/A |
| Other Working Capital | 10,621 | 881 | -9,951 | 9,369 | 577 |
| Other Operating Activity | 107 | 428 | 10,528 | -7,978 | -654 |
| Operating Cash Flow | $-1,786 | $-3,114 | $-16,068 | $-1,336 | $-1,044 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | N/A | N/A | N/A | N/A | 36,170 |
| Other Investing Activity | 0 | 0 | 4,961 | -273 | 0 |
| Investing Cash Flow | $N/A | $N/A | $4,961 | $-273 | $36,170 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 300 | N/A | 499 |
| Debt Issued | N/A | N/A | N/A | N/A | 50 |
| Debt Repayment | N/A | N/A | -5,073 | N/A | N/A |
| Common Stock Issued | 2,400 | 80 | N/A | N/A | 0 |
| Common Stock Repurchased | -30 | -215 | -354 | N/A | -36,113 |
| Other Financing Activity | -117 | 0 | 17,921 | 0 | 0 |
| Financing Cash Flow | $2,253 | $-135 | $12,794 | $N/A | $-35,564 |
| Beginning Cash Position | 917 | 4,165 | 2,479 | 4,088 | 479 |
| End Cash Position | 1,384 | 917 | 4,165 | 2,479 | 41 |
| Net Cash Flow | $467 | $-3,249 | $1,686 | $-1,609 | $-438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,786 | -3,114 | -16,068 | -1,336 | -1,044 |
| Free Cash Flow | -1,786 | -3,114 | -16,068 | -1,336 | -1,044 |